LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 4,173 | 3,163 | 4,203 | 3,407 | 3,448 |
| Operating Income | -4,173 | -3,163 | -4,203 | -3,407 | -3,448 |
| Other Income | 1 | 1 | 1 | 305 | 1,226 |
| Pre-tax Income | -4,172 | -3,162 | -4,202 | -3,102 | -2,222 |
| Net Income Continuous | -4,172 | -3,162 | -4,202 | -3,102 | -2,222 |
| Net Income | $-4,172 | $-3,162 | $-4,202 | $-3,102 | $-2,222 |
| EPS Basic Total Ops | -5.45 | -6.77 | -12.26 | -121.27 | -9.00 |
| EPS Basic Continuous Ops | -5.04 | -5.75 | -12.01 | -122.67 | -8.38 |
| EPS Diluted Total Ops | -5.45 | -6.77 | -12.26 | 0.73 | -9.00 |
| EPS Diluted Continuous Ops | -5.04 | -5.75 | -12.01 | 3.58 | -8.38 |
| EBITDA(a) | $-4,171 | $-3,163 | $-4,203 | $-3,407 | $-3,448 |